Navigating the orphan medicinal product designation: Evidence requirements for gene therapies in Europe.
Palomo GM, Pose-Boirazian T, Naumann-Winter F, Costa E, Duarte DM, Kalland ME, Malikova E, Matusevicius D, Vitezic D, Larsson K, Magrelli A, Stoyanova-Beninska V, Mariz S.
Palomo GM, et al.
Mol Ther. 2024 Oct 28:S1525-0016(24)00675-0. doi: 10.1016/j.ymthe.2024.10.015. Online ahead of print.
Mol Ther. 2024.
PMID: 39489919
Free article.